Published in Healthcare Finance, Tax and Law Weekly, December 19th, 2007
The agreement with Avani is part of Skinvisible's continued strategy to quickly expand its reach around the globe. Avani will seek licenses in India for topical products Skinvisible has developed for the treatment of acne, fungal infections, atopic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.